RAC 5.59% $1.70 race oncology ltd

Ann: Expanded Heart Protection Discovery for Zantrene, page-386

  1. 2,637 Posts.
    lightbulb Created with Sketch. 2763
    The April 2025 patent is the main compound. It is the patent 7,737,112 expiry in December 2027 that won the court case to block generic substitutes. Good example of patent thickets in action.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.